The EU's Healthcare Paradox: Treating Illness vs. Preventing It
There’s a paradox at the heart of the EU’s healthcare system that’s becoming impossible to ignore. On one hand, we’re pouring 80% of our healthcare budget into treating diseases. On the other, a mere 3-6% goes toward preventing them. It’s like spending a fortune on fixing a leaky roof while ignoring the gaping hole in the foundation. Personally, I think this imbalance isn’t just a financial issue—it’s a reflection of how we’ve come to view health itself. We’ve built systems that react to illness rather than proactively fostering wellness, and now we’re paying the price.
The Prevention Gap: A Missed Opportunity
What makes this particularly fascinating is how stark the contrast is between what we know works and what we actually do. Take cardiovascular disease (CVD), the EU’s leading cause of death. Experts agree that up to 80% of CVD cases could be prevented with existing interventions. Yet, here we are, spending €282 billion annually to treat it. From my perspective, this isn’t just a failure of policy—it’s a failure of imagination. We’ve become so entrenched in a treatment-focused mindset that we’ve forgotten prevention is not just cheaper but fundamentally more humane.
A Polycrisis Demands More Than Band-Aids
One thing that immediately stands out is the term Fraser Goodwin used: “polycrisis.” It’s not just about aging populations or rising chronic diseases—it’s about climate change, antimicrobial resistance, and a healthcare system stretched to its limits. What many people don’t realize is that these crises are interconnected. Treating them in isolation is like trying to bail out a sinking ship with a teaspoon. If you take a step back and think about it, the EU’s healthcare system isn’t just underfunded—it’s misaligned with the realities of the 21st century.
Primary Care: The Untapped Frontline
Here’s a detail that I find especially interesting: primary care, the backbone of any health system, is often relegated to a reactive role. GPs and pharmacies could be the first line of defense in prevention and early diagnosis, but instead, they’re drowning in a sea of acute cases. What this really suggests is that we’re not just underinvesting in prevention—we’re misusing the resources we already have. Repositioning primary care as a proactive force could be a game-changer, but it requires a fundamental shift in how we think about healthcare delivery.
The Role of Brussels: Multiplier or Bystander?
The EU budget might be a drop in the ocean compared to national healthcare spending, but Brussels has a unique role to play. By coordinating action across member states and holding governments accountable to WHO commitments, the EU could act as a multiplier. However, this raises a deeper question: Are we using this potential effectively? In my opinion, the EU has been too hesitant to step into this role, often deferring to national sovereignty. But in a polycrisis, coordination isn’t just helpful—it’s essential.
Innovation at Risk: The Pharma Perspective
Alexander Natz’s warning about pharmaceutical innovation is a sobering reminder that prevention isn’t the only piece of the puzzle. Geopolitical tensions, pricing disputes, and regulatory complexity are threatening Europe’s competitiveness in the global pharma market. What this really suggests is that prevention and innovation aren’t mutually exclusive—they’re two sides of the same coin. If we want a sustainable healthcare system, we need to treat the industry as a partner, not just a supplier.
The Fiscal Logic of Prevention
Olivér Várhelyi’s point about rebalancing the budget is spot on. The question isn’t whether we can afford to shift resources to prevention—it’s whether we can afford not to. The current model is a ticking time bomb, with costs spiraling out of control. But here’s the thing: prevention isn’t just about saving money. It’s about reimagining what healthcare could be—a system that prioritizes human flourishing over disease management.
Conclusion: A Call for Radical Reorientation
If there’s one takeaway from this debate, it’s that incremental changes won’t cut it. Birgit Beger’s call for a fundamental reorientation of health policy hits the nail on the head. We need tighter tobacco controls, healthier food environments, and early detection programs that actually work. But more than that, we need a cultural shift—a move away from treating health as the absence of disease and toward seeing it as a state of complete physical, mental, and social well-being.
Personally, I think this is the EU’s moment to lead. Not just in policy, but in vision. The question is: Will we seize it?
